5 services found
Oncodesign Services
-
Explore - Identification and Validation of Therapeutic Targets Service
EXPLORE, a new service to identify and validate therapeutic targets, primarily cancer treatments – an area of expertise and excellence at Oncodesign to discover and investigate preclinical proofs of concept involving a wide variety of different approaches and anti-cancer mechanisms of action. EXPLORE, is the combination of our ...
-
DRIVE-IDDS - Integrated Drug Discovery Service
DRIVE-IDDS, an integrated drug discovery solution: a complete continuum from target to clinical ...
-
Solo - Distinct and Diversified Services
An extension of our innovation technology platforms, SOLO involves a wide range of distinct and diversified services. It covers an extensive spectrum of pharmaceutical expertise and the ability to design and carry out precise and ad hoc assessments in the discovery and development of new therapies.Drawing on our experience and expertise in the preclinical investigation of new therapeutic ...
-
Inpact - Preclinical Pharmacology Service
Establishing proof of concept in preclinical pharmacology is a critical step in the drug discovery process. This is one of the decisive factors in setting the therapeutic indication(s) targeted in clinical models and in the decision to continue a new product through the regulatory preclinical and clinical steps. For more than 25 years, Oncodesign has been a player known for its ...
-
D-Vlop - Preclinical and Clinical Development Service
Complementary expertise for successful progress at each stage of your development. After the discovery and proof-of-concept phases, the preclinical development of new therapeutic entities is a critical step for the regulatory approval of the first-in-man administration and the transition to the early phases of clinical trials. D-VLOP, a network of expert partners all renowned and experienced in preclinical ...